Pfizer’s Abrysvo is the first respiratory syncytial virus vaccine that can be used for adults less than 50 years of age.
Swiss pharma giant Roche this morning reported that, in the first nine months of 2024 group sales increased by 6% at CER (2% ...
Oncosure is proud to introduce a membership plan that makes rapid cancer screening accessible to everyone. With just a simple blood draw, our all-in-one test screens for any type of cancer, detecting ...